Sort
25,944 grants matching “neurodegeneration”
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
$207,281University Of Pittsburgh At Pittsburgh · P01 · FY2001 · NS
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
$207,281University Of Pittsburgh At Pittsburgh · P01 · FY2000 · NS
Micropipette-based quantification of neuronal protein condensates in live cells
$207,247Zheng Shi · Rutgers, The State Univ Of N.J. · R21 · FY2022 · DA
CRP, inflammation, and neurodegeneration during aging
$207,241University Of Southern California · R21 · FY2005 · AG
Molecular Biological Approaches to Endocrinology
$207,240Michael G Rosenfeld · University Of California, San Diego · T32 · FY2012 · DK
Core A: Administrative Core
$207,087Victor W. Henderson · Stanford University · P50 · FY2019 · AG
The pathogenic effects of senescent cells on their microenvironments and their role in human brain aging
$206,994Habil Zare · University Of Texas Hlth Science Center · R21 · FY2025 · AG
Imaging immune signaling in virally-suppressed HIV
$206,806Jennifer Marie Coughlin · Johns Hopkins University · R21 · FY2021 · MH
BIOMARKERS AND GENETICS CORE
$206,721Joseph F Quinn · Oregon Health & Science University · P30 · FY2012 · AG
Is u-calpain a pathologic isoform?
$206,644James W Geddes · University Of Kentucky · P01 · FY2009 · NS
Development of Neurosteroids for Lysosomal Storage Disorders
$206,500Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2015 · TR
PATHOLOGY
$206,489Stephen J. Dearmond · University Of California, San Francisco · P01 · FY2009 · AG
Individualized Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
$206,449Joan A Camprodon · Massachusetts General Hospital · R21 · FY2023 · AG
STRUCTURE OF ALPHA-SYNUCLEIN AND FIBRIL ASSEMBLY
$206,412University Of Southern California · P50 · FY2005 · AG
Imaging triheteromeric NMDAR distribution and trafficking
$206,364Thomas A Blanpied · University Of Maryland Baltimore · R21 · FY2021 · MH
FUNCTION OF THE ATAXIA TELANGIECTASIA GENE PRODUCT
$206,331Beth Israel Deaconess Medical Center · R01 · FY2002 · GM
RETROMER TRAFFICKING AND ALZHEIMER'S DISEASE IN DROSOPHILA
$206,288Brian D McCabe · Columbia University Health Sciences · P50 · FY2010 · AG
The molecular mechanism of PICALM-dependent endosomal trafficking
$206,250Zhen Zhao · University Of Southern California · R21 · FY2020 · AG
Regulation of brain neuroprotection and inflammation by TIA1
$206,250Benjamin L Wolozin · Boston University Medical Campus · R21 · FY2018 · AG
Investigating the impact of p97 mutation in Amyotrophic Lateral Sclerosis
$206,250Malavika Raman · Tufts University Boston · R21 · FY2023 · NS
Effects of normal aging on the transcriptomic and physiological profiles of layer 3 pyramidal neurons in diverse neocortical areas of the monkey
$206,250Ella Zeldich · Boston University Medical Campus · R21 · FY2022 · AG
Gene edited B cells to co-express CNS-targeted antibodies
$206,250Paula M Cannon · University Of Southern California · R21 · FY2022 · MH
The contribution of X-chromosome-linked genes to cellular phenotypes and AD-related pathology in Down Syndrome
$206,250Ella Zeldich · Boston University Medical Campus · R21 · FY2024 · AG
ANALYSIS OF PROTEOMIC PATTERNS IN NEURODEGENERATION
$206,106Junmin Peng · Emory University · P50 · FY2007 · AG
A DNA origami platform for measuring membrane protein interactions
$206,094Paul W.k. Rothemund · California Institute Of Technology · R21 · FY2022 · MH